Literature DB >> 27558364

[Thymomas].

A Marx1, C-A Weis2, P Ströbel3.   

Abstract

Thymomas are rare tumors but are one of the most common mediastinal neoplasms in adults and exhibit an enormous variability in histological, biological and genetic features. The morphological spectrum within a given entity is enormous and some tumors with histological patterns of more than one entity are more common than pure histological subtypes. Due to a lack of subtype-specific markers classification of thymomas often requires complex diagnostic algorithms. The refined presentation including the definition of obligatory and optional features and of diagnostic immunohistochemical profiles, is the focus of the new World Health Organization (WHO) classification of thymomas, aiming at improving diagnostic reproducibility. This review highlights novel aspects of the WHO classification of thymomas and addresses typical differential diagnostic challenges with a focus on diagnostic pitfalls.

Entities:  

Keywords:  Differential diagnosis; Histological patterns; Immunohistochemistry; Thymic carcinoma; WHO classification

Mesh:

Substances:

Year:  2016        PMID: 27558364     DOI: 10.1007/s00292-016-0223-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

1.  The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors.

Authors:  Frank C Detterbeck; Kelly Stratton; Dorothy Giroux; Hisao Asamura; John Crowley; Conrad Falkson; Pier Luigi Filosso; Aletta A Frazier; Giuseppe Giaccone; James Huang; Jhingook Kim; Kazuya Kondo; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew G Nicholson; Meinoshin Okumura; Enrico Ruffini; Paul Van Schil
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

2.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

Review 3.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

4.  Sunitinib in thymic carcinoma: enigmas still unresolved.

Authors:  Alexander Marx; Cleo-Aron Weis
Journal:  Lancet Oncol       Date:  2015-01-13       Impact factor: 41.316

5.  Microthymoma: definition of the entity and distinction from nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).

Authors:  Wah Cheuk; William Y W Tsang; John K C Chan
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

6.  Type A and AB thymomas: histological features associated with increased stage.

Authors:  Anna C Green; Alexander Marx; Philipp Ströbel; Marianne Mason; Eric Lim; Simon Jordan; George Ladas; Michael Dusmet; Alexandra Rice; Andrew G Nicholson
Journal:  Histopathology       Date:  2014-11-10       Impact factor: 5.087

7.  On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas.

Authors:  C A Moran; S Suster
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

8.  Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.

Authors:  Philipp Ströbel; Andrea Bauer; Bernhard Puppe; Til Kraushaar; Axel Krein; Klaus Toyka; Ralf Gold; Michael Semik; Reinhard Kiefer; Wilfred Nix; Berthold Schalke; Hans Konrad Müller-Hermelink; Alexander Marx
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

9.  Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.

Authors:  Thomas Menter; Anjes Gasser; Darius Juskevicius; Stephan Dirnhofer; Alexandar Tzankov
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-08

10.  Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors.

Authors:  I Petrini; P S Meltzer; P A Zucali; J Luo; C Lee; A Santoro; H S Lee; K J Killian; Y Wang; M Tsokos; M Roncalli; S M Steinberg; Y Wang; G Giaccone
Journal:  Cell Death Dis       Date:  2012-07-19       Impact factor: 8.469

View more
  5 in total

Review 1.  [Thymic carcinomas].

Authors:  P Ströbel; C-A Weis; A Marx
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

2.  A case of thymoma in myasthenia gravis: Successful outcome after thymectomy.

Authors:  S Dahal; N Bhandari; P Dhakal; R M Karmacharya; A K Singh; S M Tuladhar; M Devbhandari
Journal:  Int J Surg Case Rep       Date:  2019-11-05

3.  Case report and literature review: thyroid carcinoma showing intrathyroid thymic carcinoma.

Authors:  Ye Yuan; Changshu Ke; Guopeng Zhang; Jun Zhang; Qianxia Li
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

4.  Analysis of deep inspiration breath-hold technique to improve dosimetric and clinical advantages in postoperative intensity-modulated radiation therapy for thymomas.

Authors:  Danfang Yan; Lihua Ning; Ying Chen; Shanbao Ke; Huijie Huang; Lihong Wang; Senxiang Yan
Journal:  Quant Imaging Med Surg       Date:  2022-08

5.  Primary mediastinal neoplasms: a report of 1,005 cases from a single institution.

Authors:  Malgorzata Szolkowska; Ewa Szczepulska-Wojcik; Beata Maksymiuk; Barbara Burakowska; Sebastian Winiarski; Juliusz Gatarek; Piotr Rudzinski; Tadeusz Orlowski; Renata Langfort
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.